e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Rare and common genetic variants of common and rare airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular diagnosis of Alpha-1 antitrypsin deficiency: a new method based on Luminex Technology
S. Ottaviani (Pavia, Italy)
Source:
International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Session:
Rare and common genetic variants of common and rare airway diseases
Session type:
Poster Discussion
Number:
4466
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ottaviani (Pavia, Italy). Molecular diagnosis of Alpha-1 antitrypsin deficiency: a new method based on Luminex Technology. 4466
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Asbestosis
Whole genome sequencing of the highly virulent subtype B0/W148 of the Beijing genotype M.tuberculosis in Kharkiv, East Ukraine
Related content which might interest you:
Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Expression analysis of different alpha-1 antitrypsin transcripts by quantitative PCR
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Implementation of screening program for alpha-1 antitrypsin deficiency in Spain
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004
The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Alpha-1 antitrypsin: functional analysis of novel variants
Source: Research Seminar 2014 - Protein quality control in lung disease
Year: 2014
Late Breaking Abstract - Genetic diagnosis of alpha-1 antitrypsin deficiency using saliva samples
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
Identification and distribution of rare and new mutations of Alpha-1-antitrypsin in Germany
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment
Year: 2021
The phenotypes and serum levels of alpha-1 antitrypsin in lung cancer patients – Preliminary results
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population - results from large scale newborn screening
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency
Source: Eur Respir J, 53 (2) 1900138; 10.1183/13993003.00138-2019
Year: 2019
Screening for alpha-1 antitrypsin deficiency in Germany – Update 2012
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012
The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Update from Central Eastern European (CEE) AAT Network
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Development of a myeloid cell-binding adenovirus for the potential gene therapy of alpha-1 anti-trypsin deficiency
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020
Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Research priorities in alpha-1 antitrypsin deficiency (AATD) for healthcare professionals
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Screening of alpha-1 antitrypsin deficiency in a blood donors cohort of the North-Italian area
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept